• Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto

  2026-04-29

  This study uncovers a methyltransferase-mediated mechanism in Salmonella Typhimurium that enhances bacterial haem biosynthesis, thereby inhibiting macrophage phagocytosis and promoting virulence in mice. The findings highlight pathogen-derived haem as a critical modulator of host immune evasion, opening new avenues for dissecting bacterial strategies in host-pathogen interactions.

• I-BET151 (GSK1210151A): Protocols & Innovations in Cancer Bi

  2026-04-28

  I-BET151 (GSK1210151A) empowers precise dissection of BET-regulated transcriptional programs and cell fate in cancer research. This article spotlights experimental protocols, advanced use-cases, and troubleshooting strategies for maximizing the impact of this selective BET inhibitor.

• Distinct Mechanisms of Gepotidacin and Fluoroquinolones Targ

  2026-04-28

  This article reviews the mechanistic and structural insights from the study of gepotidacin’s inhibition of Staphylococcus aureus gyrase, highlighting how its mode of action diverges from traditional fluoroquinolone antibiotics. The findings inform future research on antibacterial strategies, especially in the context of rising fluoroquinolone resistance.

• Spiroplasma eriocheiris Entry: Clathrin-Mediated Endocytosis

  2026-04-27

  This study establishes Drosophila Schneider 2 (S2) cells as a model for Spiroplasma eriocheiris infection, revealing that entry relies on clathrin-mediated endocytosis and macropinocytosis. Functional inhibition experiments provide mechanistic evidence, with implications for dissecting endocytic pathways in host-pathogen interactions.

• Deep Learning Enables High-Content Cardiotoxicity Screening

  2026-04-27

  Grafton et al. introduce a scalable deep-learning approach to detect drug-induced cardiotoxicity using high-content imaging of iPSC-derived cardiomyocytes. This method allows rapid screening of diverse compound libraries, advancing cardiac safety assessment in early-stage drug discovery.

• MDL 28170 Calpain Inhibitor: Applied Workflows & Optimizatio

  2026-04-26

  MDL 28170, a highly selective calpain inhibitor from APExBIO, empowers translational research across neuroprotection, cardiac, and infectious disease models with robust, reproducible inhibition of cysteine proteases. This guide delivers evidence-driven protocol enhancements, troubleshooting strategies, and unique cross-domain insights for maximizing experimental impact.

• KIR2.1 Inhibition Reduces PASMC Proliferation via TGF-β/Smad

  2026-04-25

  This study demonstrates that KIR2.1 contributes to pulmonary artery smooth muscle cell (PASMC) proliferation and migration through activation of the TGF-β1/Smad2/3 pathway, a key process in pulmonary vascular remodeling. Targeting either KIR2.1 or TGF-β signaling with specific inhibitors like SB 431542 effectively reduced PASMC proliferation, suggesting potential therapeutic avenues for pulmonary hypertension.

• LG 101506: RXR Modulator for Nuclear Receptor Research

  2026-04-24

  LG 101506 is a high-purity RXR modulator used in nuclear receptor signaling research. This article details its mechanism, benchmarks, and best practices for experimental integration, emphasizing its application in the study of RXR pathways and related disease models.

• Nicotinamide Riboside Chloride: Advancing NAD+ in Disease Mo

  2026-04-24

  Nicotinamide Riboside Chloride (NIAGEN) empowers precision control over NAD+ metabolism for both metabolic dysfunction and neurodegenerative disease research. Discover optimized workflows, advanced applications, and targeted troubleshooting tips that maximize reproducibility and data integrity in translational models.

• SU5416 (Semaxanib): Optimizing Angiogenesis Inhibition Workf

  2026-04-23

  SU5416 (Semaxanib) stands out as a selective inhibitor for VEGF-induced angiogenesis, enabling rigorous suppression of tumor vascularization and robust immune modulation. This article delivers practical workflow enhancements, troubleshooting tips, and evidence-driven parameters to maximize reproducibility with SU5416 in cancer and vascular research.

• Evaluating Drug Responses in Cancer: Insights from In Vitro

  2026-04-23

  Schwartz’s dissertation critically re-examines how drug-induced proliferation arrest and cell death are measured in in vitro cancer systems. By distinguishing between relative and fractional viability, the work reveals that most anticancer agents—including epigenetic modulators—invoke both growth inhibition and cytotoxicity, but with different timing and magnitude, informing improved experimental design and interpretation.

• Bestatin Enables Chemical Genetics Dissection of Jasmonate S

  2026-04-22

  Zheng et al. (2006) established bestatin as a selective chemical probe for jasmonate signaling in Arabidopsis, revealing new genetic loci involved in plant defense and development. Their multifaceted approach advanced understanding of hormone signaling pathways and offers a template for future chemical genetics studies.

• CHIR-99021 (CT99021): Potent GSK-3 Inhibitor for Stem Cell C

  2026-04-22

  CHIR-99021 (CT99021) is a highly selective and potent small molecule GSK-3 inhibitor. It enables precision modulation of Wnt/β-catenin signaling and the maintenance of embryonic stem cell pluripotency. The compound’s specificity and robust experimental benchmarks make it a foundational reagent for advanced stem cell and developmental biology workflows.

• Glabridin-Gold(I) Complex Modulates TrxR/MAPK for Antitumor

  2026-04-21

  This study introduces a glabridin-gold(I) complex (6d) as a dual inhibitor of thioredoxin reductase and MAPK pathways, aiming to enhance antitumor immunity by reshaping the tumor microenvironment. The findings provide mechanistic insights into immunomodulation via ROS and highlight the potential for synergy with immunotherapies.

• Thiothixene Stimulates Macrophage Efferocytosis via Arginase

  2026-04-21

  Kojima et al. demonstrate that thiothixene, a typical antipsychotic agent, uniquely enhances continual efferocytosis in macrophages by upregulating the vitamin A pathway and Arginase 1 expression. These findings bridge neuropharmacology and immunological cell clearance, with implications for diseases marked by impaired efferocytosis.

407 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page